Click a link below to view the mailing archive as if it had been sent to you.
| 2021-11-30 12:15 | | GlaxoSmithKline poaches Pfizer vax leader Dormitzer after hemorrhaging vaccine R&D talent and more... |
| 2021-11-30 00:15 | | Promising Signals Emerge from Two Phase II Cancer Studies and more... |
| 2021-11-29 12:15 | | Former Insys execs ordered to pay $48.3 million in restitution in Subsys opioid trial and more... |
| 2021-11-29 00:15 | | Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch? and more... |
| 2021-11-27 00:15 | | New Merck study results raise questions about its COVID-19 pill and more... |
| 2021-11-24 12:15 | | What to Expect at ASH: CAR T Results in Lymphoma, Data on IDH1+ AML, and More and more... |
| 2021-11-24 00:15 | | Pfizer to become $100B behemoth next year thanks to COVID-19 drug and vaccine: analyst and more... |
| 2021-11-23 12:15 | | AstraZeneca opens new advance therapeutics R&D facility in Cambridge and more... |
| 2021-11-23 00:15 | | Study: Biogen’s Aduhelm Caused Brain Swelling in Over One-Third of Study Participants and more... |
| 2021-11-22 12:15 | | Xencor finally finds buyer for onetime lead drug, offloading autoimmune asset to Tesaro co-founder in backloaded deal and more... |
| 2021-11-21 00:15 | | FDA asks for 55 years to complete FOIA request on Pfizer's COVID-19 vaccine | FiercePharma and more... |
| 2021-11-20 12:15 | | Biogen seeking more information in investigation of Aduhelm patient's death and more... |
| 2021-11-19 12:15 | | FDA expands emergency authorization for Covid-19 booster shots to all adults and more... |
| 2021-11-19 00:15 | | Johnson & Johnson expects 14 new blockbusters by the middle of the decade, execs say and more... |
| 2021-11-18 12:15 | | Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna and more... |
| 2021-11-18 00:15 | | Three Pharma Companies Seek to Address FDA Rejections and more... |
| 2021-11-17 12:15 | | Johnson and Johnson’s new vaccines leader talks Covid-19, pipeline plans, and ‘a golden opportunity’ for clinical trials and more... |
| 2021-11-17 00:15 | | Pfizer, US in talks for 'multibillion-dollar' supply deal for COVID-19 pill and more... |
| 2021-11-16 12:15 | | End-of-Year Restructuring Means Layoffs for These Companies and more... |
| 2021-11-16 00:15 | | Biogen's research chief Alfred Sandrock to retire and more... |
| 2021-11-15 12:15 | | Protagonist posts phase 2 hormone replacement data, pitching for lead role in genetic iron overload disease and more... |
| 2021-11-15 00:15 | | Here Are The Industries With The Highest — And Lowest — Covid Vaccination Rates, Poll Finds and more... |
| 2021-11-14 00:15 | | A couple months ahead of its PDUFA data, Bristol Myers rolls out long-term data for mavacamten and more... |
| 2021-11-12 12:15 | | J&J, world's largest drugmaker, plans to split in two and more... |
| 2021-11-12 00:15 | | Moderna, escalating dispute with NIH, claims government had no role in key vaccine patent and more... |
| 2021-11-11 12:15 | | CPhI: As Covid-19 restrictions ease, an inspection backlog could have a big effect on new drugs, generics and more... |
| 2021-11-11 00:15 | | Kaléo Inc. Agrees to Pay $12.7 Million to Resolve Allegations of False Claims for Anti-Overdose Drug and more... |
| 2021-11-10 12:15 | | White House says 900,000 5- to 11-year-olds were vaccinated during first week of eligibility for scaled-down dose and more... |
| 2021-11-10 00:15 | | Biogen's Aduhelm records one patient death. Is the controversial Alzheimer’s drug to blame? and more... |
| 2021-11-09 12:15 | | US pays $1B to nearly double supply of Merck's COVID-19 pill and more... |
| 2021-11-09 00:15 | | Once-failed cancer drug from BioXcel ramps up immunotherapy in mouse models of pancreatic cancer and more... |
| 2021-11-08 12:15 | | Regeneron COVID-19 antibody drug reduces infection risk 82% in clinical trial and more... |
| 2021-11-08 00:15 | | Moderna's President Just Gave Us a Clue About the Size of Tomorrow's Vaccine Market and more... |
| 2021-11-06 00:15 | | Pfizer says its Covid pill with HIV drug cuts the risk of hospitalization or death by 89% and more... |
| 2021-11-05 12:15 | | Novartis’ iptacopan hits the mark in rare kidney disease C3G and more... |
| 2021-11-04 12:15 | | Novartis to sell its Roche stake for $20.7 billion and more... |
| 2021-11-04 00:15 | | Lilly pulls COVID-19 treatment from EU review while U.S. stocks up and more... |
| 2021-11-03 12:15 | | Testimony: Elizabeth Holmes Mislead Investors with Use of Schering-Plough Logo and more... |
| 2021-11-03 00:15 | | CDC panel unanimously backs use of Pfizer's COVID-19 vaccine in young children and more... |
| 2021-11-02 12:15 | | California judge sides with drugmakers in $50B opioid lawsuit and more... |
| 2021-11-02 00:15 | | Amid a push to resolve opioid and talc claims, Johnson & Johnson settles Risperdal litigation for $800M and more... |
| 2021-11-01 12:15 | | A three-decade monopoly: How Amgen built a patent thicket around its top-selling drug and more... |
